Cargando…
Effect of bremelanotide on body weight of obese women: Data from two phase 1 randomized controlled trials
AIMS: The melanocortin 4 receptor (MC4R) plays a central role in appetite regulation, and agonistic activity at this receptor promotes satiety. Results from two randomized controlled clinical trials examine the effects of bremelanotide's agonism at MC4R on caloric intake and body weight. METHOD...
Autores principales: | Spana, Carl, Jordan, Robert, Fischkoff, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314948/ https://www.ncbi.nlm.nih.gov/pubmed/35170192 http://dx.doi.org/10.1111/dom.14672 |
Ejemplares similares
-
Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial
por: Clayton, Anita H, et al.
Publicado: (2016) -
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
por: Kingsberg, Sheryl A., et al.
Publicado: (2019) -
Bremelanotide for Treatment of Female Hypoactive Sexual Desire
por: Edinoff, Amber N., et al.
Publicado: (2022) -
Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2019) -
Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide
por: White, William B., et al.
Publicado: (2017)